Monday, November 21, 2016

BRIEF-MaRS Innovation announces acquisition of first compound from Triphase by Celgene

* Triphase accelerator to sell assets relating to Marizomib

to Celgene, via affiliate, for undisclosed amount

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)